Compare Marqeta Inc (MQ) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Marqeta Inc vs Moderna, Inc. — how do they compare? Marqeta Inc trades at $17.22 (market cap $1.85B), while Moderna, Inc. trades at $59.73 (market cap $23.60B). The key difference: Moderna, Inc. is far larger — about 12.8× Marqeta Inc's market cap, and Moderna, Inc. is trading nearer its 52-week high, Marqeta Inc nearer its low. Which is the better fit depends on your goals.
| MQ | MRNA | |
|---|---|---|
Market Cap | $1.85B | $23.60B |
Sector | Technology | Health |
52-Week High | $27.32 | $81.80 |
52-Week Low | $15.04 | $22.36 |
Enterprise Value | $1.15B | $19.70B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Marqeta Inc
Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.
Read more on MQ →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
